Search by Drug Name or NDC
NDC 25021-0790-02 PROCHLORPERAZINE EDISYLATE 5 mg/mL Details
PROCHLORPERAZINE EDISYLATE 5 mg/mL
PROCHLORPERAZINE EDISYLATE is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is PROCHLORPERAZINE EDISYLATE.
Product Information
| NDC | 25021-0790 |
|---|---|
| Product ID | 25021-790_18174b35-89ba-487a-bbc5-95716b8c1274 |
| Associated GPIs | 59200055202010 |
| GCN Sequence Number | 067700 |
| GCN Sequence Number Description | prochlorperazine edisylate VIAL 10 MG/2 ML INJECTION |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 30314 |
| HICL Sequence Number | 001628 |
| HICL Sequence Number Description | PROCHLORPERAZINE EDISYLATE |
| Brand/Generic | Generic |
| Proprietary Name | PROCHLORPERAZINE EDISYLATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PROCHLORPERAZINE EDISYLATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | PROCHLORPERAZINE EDISYLATE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214107 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0790-02 (25021079002)
| NDC Package Code | 25021-790-02 |
|---|---|
| Billing NDC | 25021079002 |
| Package | 10 VIAL in 1 CARTON (25021-790-02) / 2 mL in 1 VIAL |
| Marketing Start Date | 2021-11-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |